Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of ECG-derived Atrial Fibrillatory Rate for Prediction of the Outcome of Cardioversion of Short Duration Atrial Fibrillation

NCT02112318 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT02112318
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02112318 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of ECG-derived Atrial Fibrillatory Rate for Prediction of the Outcome of Cardioversion of Short Duration Atrial Fibrillation
Lead sponsor
Region Skane
Phase
Observational
Overall status
Terminated
Start date
January 31, 2013
Completion date
March 31, 2021
Enrollment
32 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, electrical remodeling, electrocardiography